Free p-cresol is associated with cardiovascular disease in hemodialysis patients (Q46729408)

24 December 2017

title

Free p-cresol is associated with cardiovascular disease in hemodialysis patients (English)

1 reference

24 December 2017

main subject

patient

0 references

cardiovascular disease

1 reference

B K I Meijers

1

1 reference

24 December 2017

B Bammens

2

1 reference

24 December 2017

B De Moor

3

1 reference

24 December 2017

K Verbeke

4

1 reference

24 December 2017

Y Vanrenterghem

5

1 reference

24 December 2017

P Evenepoel

6

1 reference

24 December 2017

language of work or name

English

0 references

publication date

27 February 2008

1 reference

24 December 2017

published in

Kidney International

1 reference

24 December 2017

volume

73

1 reference

24 December 2017

page(s)

1174-1180

1 reference

24 December 2017

issue

10

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.2008.31

exact match

0 references

cites work

Chronic kidney disease: effects on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Cardiovascular disease risk factors in chronic renal insufficiency.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

C-reactive protein is associated with renal function abnormalities in a non-diabetic population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Role of hypoalbuminemia and hypocholesterolemia as copredictors of mortality in acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Review on uremic toxins: classification, concentration, and interindividual variability

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Protein-bound uremic solutes: the forgotten toxins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Uremic retention solutes: the free and the bound

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Effect of dialysis dose and membrane flux in maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Elevation of circulating endothelial microparticles in patients with chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Survival advantages of obesity in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Cardiovascular biomarkers: added value with an integrated approach?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Use and misuse of the receiver operating characteristic curve in risk prediction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Residual renal function and mortality risk in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Toxicity of free p-cresol: a prospective and cross-sectional analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Association between blood indoxyl sulfate and carbonyl stress marker in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Removal of P-cresol sulfate by hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

p-Cresol for better or worse: but what are we measuring?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Major coagulation disturbances during fractionated plasma separation and adsorption

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.31

7 January 2021

Identifiers

DOI

10.1038/KI.2008.31

1 reference

24 December 2017

PubMed ID

18305466

1 reference

24 December 2017